CAS 1246817-44-6

Formel: C25H25N7O3

InChl: InChI=1S/C25H25N7O3/c1-31-20-10-7-17(25(35)32(13-11-23(33)34)21-4-2-3-12-28-21)14-19(20)30-22(31)15-29-18-8-5-16(6-9-18)24(26)27/h2-10,12,14,29H,11,13,15H2,1H3,(H3,26,27)(H,33,34)/i1D3

InChI Key: YBSJFWOBGCMAKL-FIBGUPNXSA-N

SMILES: [2H]C([2H])([2H])N1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N

Dabigatran-d3

CAS: 1246817-44-6

Dabigatran-d3

Formel: C₂₅H₂₂D₃N₇O₃

Reinheit: 95%

Molekulargewicht: 474.53

Ref: 54-DE3505

Dabigatran-D3

CAS: 1246817-44-6

Dabigatran-d3 is a deuterated compound of Dabigatran.

Formel: C₂₅H₂₂D₃N₇O₃

Molekulargewicht: 474.53

Ref: TM-TMIH-0174

Dabigatran-d3

Kontrolliertes Produkt

CAS: 1246817-44-6

Applications Labelled Dabigatran (D100090). Nonpeptide, direct thrombin inhibitor. Antithrombotic.
References Hauel, N., et al.: J. Med. Chem., 45, 1757 (2002), Mungall, D., et al.: Curr. Opin. Invest. Drugs, 3, 095 (2002), Stangier, J., et al.: J. Clin. Pharmacol., 45, 555 (2005),

Formel: C₂₅₂H₃H₂₂N₇O₃

Reinheit: >90%

Farbe und Form: Neat

Molekulargewicht: 474.53

Ref: TR-D100092

Dabigatran-d3

CAS: 1246817-44-6

Formel: C₂₅H₂₅N₇O₃

Molekulargewicht: 474.5

Ref: BE-RMCD001059

Dabigatran-d3

CAS: 1246817-44-6

Formel: C₂₅H₂₅N₇O₃

Molekulargewicht: 474.5

Ref: BE-RMCD001145

Dabigatran-d3

CAS: 1246817-44-6

Dabigatran-d3 is a potent inhibitor of kinases that has shown promising anticancer activity. This analog of Dabigatran has been shown to induce apoptosis in cancer cells and inhibit tumor growth, making it a potential candidate for the treatment of cancer. Dabigatran-d3 works by inhibiting the activity of kinases, which are enzymes that play a critical role in cell signaling pathways. It has been shown to be effective against various types of cancer, including Chinese hamster ovary cells and human breast cancer cells. Additionally, Dabigatran-d3 can be detected in urine samples, making it a useful tool for monitoring drug levels during clinical trials. Overall, this kinase inhibitor shows great promise as an anticancer agent with significant potential for further development.

Formel: C₂₅H₂₅N₇O₃

Reinheit: Min. 95%

Molekulargewicht: 474.5 g/mol

Ref: 3D-WZB81744

Dabigatran-d3

CAS: 1246817-44-6

Formel: C₂₅H₂₂D₃N₇O₃

Molekulargewicht: 474.5

Ref: ST-EA-CP-IL0191